CDC's Advisory Committee on Immunization Practices (ACIP) annually reviews the recommended Adult
Immunization Schedule to ensure that the schedule reflects current recommendations for the use of licensed vaccines. In June 2004, ACIP approved the Adult Immunization Schedule for October 2004--September 2005. This schedule has also been
approved by the American Academy of Family Physicians and the American College of Obstetricians and Gynecologists.
Changes in the Schedule for October 2004--September 2005
The 2004--2005 schedule differs from the previous schedule as follows:
Both figures now provide a separate row for each vaccine (Figures 1 and 2).
Health-care workers have been added to the figure that provides immunization recommendations by
medical indications and other conditions (Figure 2).
The special note regarding influenza vaccination of pregnant women reflects the revised ACIP recommendations that all pregnant women should receive influenza vaccination regardless of preexisting chronic conditions
(1).
Health-care workers were added to the Adult Immunization Schedule in response to provider requests; this change
should facilitate assessment of the vaccination status of health-care workers and administration of needed vaccinations. In 2002, 38.4% of health-care workers reported influenza vaccination, and 62.3% reported having completed hepatitis
B vaccination series (National Health Interview Survey, CDC, unpublished data, 2003). Influenza vaccination of
health-care workers is an important preventive measure for persons at high risk for complications from influenza infection. Health-care workers involved in direct patient care are among the priority groups recommended to receive influenza vaccination for the 2004--05 influenza season, despite the vaccine shortage
(2).
The Adult Immunization Schedule is available in English and Spanish at
http://www.cdc.gov/nip/recs/adult-schedule.htm. General information about adult immunization, including recommendations concerning vaccination of persons with human immunodeficiency virus (HIV) and other immunosuppressive conditions, is available from state and local health
departments and from the National Immunization Program at
http://www.cdc.gov/nip. Vaccine information statements are available at
http://www.cdc.gov/nip/publications/vis. ACIP statements for each recommended vaccine can be viewed, downloaded,
and printed from CDC's National Immunization Program at http://www.cdc.gov/nip/publications/acip-list.htm. Instructions
for reporting adverse events after vaccination to the Vaccine Adverse Event Reporting System (VAERS) are available at
http://www.vaers.org or by telephone, 800-822-7967.
This schedule indicates the recommended age groups for routine administration of currently licensed vaccines for persons aged
>19 years. Licensed combination vaccines may be used whenever any components of the combination are indicated and when the vaccine's other components are not contraindicated. Providers should consult manufacturers' package inserts for detailed recommendations. Report all clinically significant postvaccination reactions to the Vaccine Adverse Event Reporting
System (VAERS). Reporting forms and instructions on filing a VAERS report are available by telephone, 800-822-7967, or from the VAERS website at
http://www.vaers.prg.
Information on how to file a Vaccine Injury Compensation Program claim is available at
http://www.hrsa.gov/osp/vicp or by telephone, 800-338-2382. To file a claim for
vaccine injury, contact the U.S. Court of Federal Claims, 717 Madison Place, N.W., Washington, DC 20005, telephone 202-219-9657.
Additional information about the vaccines listed above and contraindications for immunization is available at
http://www.cdc.gov/nip or from the National Immunization Hotline, 800-232-2522 (English) or 800-232-0233 (Spanish). Approved by the
Advisory Committee on Immunization Practices
(ACIP), the American College of Obstetricians and Gynecologists (ACOG), and the American Academy of Family Physicians (AAFP).
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
